Yarrow Bioscience Inc (YARW) Balance Sheet
YARW balance sheet, 2025
December 31, 2025 · U.S. dollars$30.2M assets = $2.4M liabilities + $27.8M equity
Both columns are drawn to the same scale: what YARW owns equals what it owes plus shareholders’ equity. Hover a block for its value.
YARW financial health
Descriptive bands, not a rating. Fiscal 2025.
YARW balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $42.1M2016 | $30.2M2025 | −3.6%/yr | |
| Total liabilities | $71.5M2016 | $2.4M2025 | −31.4%/yr | |
| Shareholders’ equity | −$29.4M2016 | $27.8M2025 | — | |
| Cash & short-term investments | $30.9M2016 | $29.0M2025 | −0.7%/yr | |
| Total debt | $700,0002019 | $99,0002024 | −32.4%/yr | |
| Net cash (debt) | $76.2M2019 | $61.4M2024 | −$14.8M | |
| Working capital | $27.6M2016 | $27.6M2025 | −$22,000 | |
| Debt / equity | 0.012019 | 0.002024 | −0.01 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
YARW assets
YARW liabilities and equity
YARW debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
YARW balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $29.0M | $61.5M | $93.3M | $30.9M | $42.2M | $58.6M | $76.9M | $136.2M | $62.5M | $30.9M |
| Cash & equivalents | $24.0M | $19.9M | $30.6M | $30.9M | $42.2M | $57.6M | $30.8M | $49.5M | $10.2M | $4.0M |
| Short-term investments | $5.0M | $41.6M | $62.6M | — | — | $1.0M | $46.2M | $86.7M | $49.3M | $26.9M |
| Receivables | $0 | $0 | $0 | $5.0M | $7.6M | $15.8M | $0 | $0 | $786,000 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $7.3M | $7.4M | $0 | $0 | −$3.0M | $0 |
| Other current assets | $1.0M | $2.9M | $2.7M | $2.4M | $6.1M | $5.4M | $1.4M | $3.2M | $3.6M | $632,000 |
| Total current assets | $30.0M | $64.4M | $96.0M | $38.3M | $63.2M | $87.3M | $78.3M | $139.5M | $63.9M | $31.5M |
| Property, plant & equipment (net) | $90,000 | $206,000 | $207,000 | $0 | $354,000 | $2.1M | $769,000 | $146,000 | $28,000 | $27,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $60,000 | $2.3M | $1.5M | $2.5M | $3.5M | $4.3M | $73,000 | $282,000 | $3.0M | $10.5M |
| Total assets | $30.2M | $66.9M | $97.7M | $40.8M | $67.0M | $93.7M | $79.2M | $139.9M | $66.9M | $42.1M |
| Liabilities | ||||||||||
| Accounts payable | $1.0M | $2.7M | $1.7M | $2.4M | $6.5M | $4.8M | $3.8M | $3.3M | $2.5M | $1.5M |
| Short-term debt | — | $99,000 | $115,000 | — | $349,000 | $757,000 | $700,000 | — | — | — |
| Deferred revenue | — | — | — | — | — | — | — | — | $1.8M | $1.8M |
| Total current liabilities | $2.4M | $14.8M | $7.5M | $9.3M | $18.4M | $21.8M | $10.7M | $9.5M | $7.8M | $3.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $1.4M | $211,000 | $0 | $34.5M | $0 | $7,000 | $116.1M | $67.6M |
| Total liabilities | $2.4M | $14.8M | $8.9M | $9.6M | $18.4M | $56.2M | $10.7M | $9.6M | $123.9M | $71.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,000 | $1,000 | $1,000 | — | $5,000 | $4,000 | $3,000 | $3,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$757.7M | −$731.2M | −$691.3M | −$662.7M | −$639.5M | −$566.2M | −$184.3M | −$110.6M | −$59.2M | −$30.1M |
| Accumulated other comprehensive income | $2,000 | $20,000 | $26,000 | — | — | — | $24,000 | −$96,000 | −$51,000 | −$26,000 |
| Total shareholders' equity | $27.8M | $52.1M | $88.7M | $31.2M | $48.6M | $37.5M | $68.5M | $130.4M | −$57.0M | −$29.4M |
| Key figures | ||||||||||
| Total debt | — | $99,000 | $214,000 | — | $349,000 | $34.8M | $700,000 | — | — | — |
| Net cash (debt) | — | $61.4M | $93.0M | — | $41.9M | $23.8M | $76.2M | — | — | — |
| Working capital | $27.6M | $49.6M | $88.4M | $28.9M | $44.8M | $65.5M | $67.7M | $130.0M | $56.0M | $27.6M |
| Tangible book value | $27.8M | $52.1M | $88.7M | $31.2M | $48.6M | $37.5M | $68.5M | $130.4M | −$57.0M | −$29.4M |
| Current ratio | 12.53 | 4.35 | 12.73 | 4.10 | 3.43 | 4.01 | 7.35 | 14.62 | 8.17 | 8.08 |
| Quick ratio | 12.11 | 4.15 | 12.37 | 3.84 | 2.71 | 3.42 | 7.22 | 14.28 | 8.09 | 7.92 |
| Debt / equity | — | 0.00 | 0.00 | — | 0.01 | 0.93 | 0.01 | — | — | — |
| Equity / assets | 92.1% | 77.9% | 90.8% | 76.6% | 72.5% | 40.0% | 86.5% | 93.2% | −85.3% | −70.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $22.9M | $24.9M | $29.0M | $32.7M | $39.6M | $50.3M | $61.5M | $70.2M | $78.1M | $86.0M | $93.3M | $15.4M |
| Cash & equivalents | $22.9M | $24.6M | $24.0M | $19.3M | $22.0M | $28.2M | $19.9M | $16.3M | $29.6M | $19.1M | $30.6M | $15.4M |
| Short-term investments | $0 | $297,000 | $5.0M | $13.4M | $17.6M | $22.1M | $41.6M | $53.9M | $48.5M | $66.9M | $62.6M | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $250,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $54,000 |
| Other current assets | $601,000 | $861,000 | $1.0M | $3.2M | $4.7M | $4.6M | $2.9M | $3.4M | $5.7M | $4.2M | $2.7M | $1.8M |
| Total current assets | $23.5M | $25.8M | $30.0M | $35.9M | $44.3M | $54.9M | $64.4M | $73.5M | $83.8M | $90.2M | $96.0M | $17.5M |
| Property, plant & equipment (net) | $78,000 | $84,000 | $90,000 | $96,000 | $134,000 | $169,000 | $206,000 | $122,000 | $151,000 | $180,000 | $207,000 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $60,000 | $150,000 | $241,000 | $1.3M | $2.3M | $2.5M | $2.7M | $1.3M | $1.5M | $1.8M |
| Total assets | $23.6M | $25.9M | $30.2M | $36.1M | $44.7M | $56.4M | $66.9M | $76.2M | $86.6M | $91.7M | $97.7M | $19.3M |
| Liabilities | ||||||||||||
| Accounts payable | $614,000 | $261,000 | $1.0M | $1.2M | $1.4M | $3.5M | $2.7M | $4.0M | $4.5M | $2.8M | $1.7M | $716,000 |
| Short-term debt | — | — | — | — | $25,000 | $63,000 | $99,000 | $123,000 | $120,000 | $117,000 | $115,000 | — |
| Total current liabilities | $1.5M | $1.2M | $2.4M | $4.0M | $5.8M | $12.3M | $14.8M | $12.7M | $11.8M | $6.9M | $7.5M | $6.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $25,000 | $1.4M | $1.4M | $1.3M |
| Total liabilities | $1.5M | $1.2M | $2.4M | $4.0M | $5.8M | $12.3M | $14.8M | $12.7M | $11.8M | $8.3M | $8.9M | $7.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | — | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | — |
| Retained earnings (deficit) | −$764.2M | −$761.2M | −$757.7M | −$752.8M | −$745.5M | −$739.8M | −$731.2M | −$719.1M | −$707.0M | −$697.6M | −$691.3M | −$685.1M |
| Accumulated other comprehensive income | — | — | $2,000 | $4,000 | −$2,000 | — | $20,000 | $34,000 | −$58,000 | −$70,000 | $26,000 | — |
| Total shareholders' equity | $22.1M | $24.6M | $27.8M | $32.1M | $38.9M | $44.1M | $52.1M | $63.5M | $74.9M | $83.4M | $88.7M | $11.5M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | $25,000 | $63,000 | $99,000 | $123,000 | $145,000 | $180,000 | $214,000 | — |
| Net cash (debt) | — | — | — | — | $39.6M | $50.2M | $61.4M | $70.1M | $78.0M | $85.8M | $93.0M | — |
| Working capital | $22.0M | $24.6M | $27.6M | $31.8M | $38.5M | $42.6M | $49.6M | $60.9M | $72.0M | $83.3M | $88.4M | $11.1M |
| Tangible book value | $22.1M | $24.6M | $27.8M | $32.1M | $38.9M | $44.1M | $52.1M | $63.5M | $74.9M | $83.4M | $88.7M | $11.5M |
| Current ratio | 15.26 | 20.86 | 12.53 | 8.87 | 7.60 | 4.47 | 4.35 | 5.81 | 7.13 | 13.02 | 12.73 | 2.72 |
| Quick ratio | 14.87 | 20.17 | 12.11 | 8.09 | 6.79 | 4.09 | 4.15 | 5.54 | 6.64 | 12.41 | 12.37 | 2.43 |
| Debt / equity | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Equity / assets | 93.5% | 95.2% | 92.1% | 88.8% | 86.9% | 78.2% | 77.9% | 83.4% | 86.4% | 90.9% | 90.8% | 59.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 27, 2026); data from EODHD.
YARW financial position
At the end of fiscal 2025 (December 31, 2025), Yarrow Bioscience had total assets of $30.2 million (down 54.9% from a year earlier), total liabilities of $2.4 million and shareholders' equity of $27.8 million. Its current ratio was 12.53. In the latest quarter (ended June 30, 2026) total assets were $23.6 million and equity $22.1 million.
Related: YARW income statement, YARW cash flow statement, YARW key metrics. See the YARW stock overview for the latest quote and news.
YARW balance sheet FAQ
What are Yarrow Bioscience's total assets?
Yarrow Bioscience reported total assets of $30.2 million at the end of fiscal 2025 (December 31, 2025), compared with $66.9 million a year earlier.
How much cash does Yarrow Bioscience have?
Yarrow Bioscience held $29.0 million in cash and short-term investments at the end of fiscal 2025.
What is Yarrow Bioscience's book value?
Yarrow Bioscience's shareholders' equity (book value) was $27.8 million at the end of fiscal 2025.
What is Yarrow Bioscience's current ratio?
Yarrow Bioscience had current assets of $30.0 million and current liabilities of $2.4 million, a current ratio of 12.53 (it can cover its short-term obligations).